Cargando…

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer

PURPOSE: Breast cancer tumour-infiltrating lymphocytes associate with clinico-pathological factors, including survival, although the literature includes many conflicting findings. Our aim was to assess these associations for key lymphocyte subtypes and in different tumour compartments, to determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Rashmi, Hanby, Andrew M., Horgan, Kieran, Verghese, Eldo T., Volpato, Milene, Carter, Clive R., Hughes, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376517/ https://www.ncbi.nlm.nih.gov/pubmed/32577938 http://dx.doi.org/10.1007/s10549-020-05757-5

Ejemplares similares

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
por: Al Amri, Waleed S., et al.
Publicado: (2020)

The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
por: Tiainen, Satu, et al.
Publicado: (2020)

Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer
por: Verma, Rashmi, et al.
Publicado: (2016)

T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019)

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
por: Eustace, A. J., et al.
Publicado: (2021)

Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
por: Hida, Akira I., et al.
Publicado: (2016)

The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer
por: Jääskeläinen, Minna M., et al.
Publicado: (2023)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors
por: Grenader, Tal, et al.
Publicado: (2020)

Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns
por: Bardowell, Sabrina A., et al.
Publicado: (2013)

PSMD9 expression predicts radiotherapy response in breast cancer
por: Langlands, Fiona E, et al.
Publicado: (2014)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis
por: Zwager, Mieke C., et al.
Publicado: (2023)

Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
por: Yazaki, Shu, et al.
Publicado: (2022)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy Induces Expression Levels of Breast Cancer Resistance Protein That Predict Disease-Free Survival in Breast Cancer
por: Kim, Baek, et al.
Publicado: (2013)

S47. Tumour infiltrating lymphocytes - a predictive marker?
por: Galon, J
Publicado: (2014)

Tumour-infiltrating lymphocytes: from prognosis to treatment selection
por: Brummel, Koen, et al.
Publicado: (2022)

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
por: Naghavian, Reza, et al.
Publicado: (2023)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
por: Loi, Sherene
Publicado: (2013)

Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model
por: Satooka, Hiroki, et al.
Publicado: (2020)

CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes
por: Kerekes, Daniel, et al.
Publicado: (2017)

Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.
por: Trentin, L., et al.
Publicado: (1994)

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
por: Whitford, P., et al.
Publicado: (1990)

Matrix Metalloproteinases in Cytotoxic Lymphocytes Impact on Tumour Infiltration and Immunomodulation
por: Edsparr, Karin, et al.
Publicado: (2010)

Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes
por: Galetta, Henry, et al.
Publicado: (2015)

Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma
por: Maddison, Kelsey, et al.
Publicado: (2021)

Stromal fibroblasts with nuclear β-catenin are present within breast tumours and increase proliferation and invasion of epithelial breast cancer cells
por: Verghese, E, et al.
Publicado: (2008)

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance
por: Kuilman, Midas M., et al.
Publicado: (2022)

Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis
por: Gao, Zhao-hua, et al.
Publicado: (2020)

T-cell receptor gene expression in tumour-infiltrating lymphocytes and peripheral blood lymphocytes of patients with nasopharyngeal carcinoma.
por: Chen, Y., et al.
Publicado: (1995)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Intrinsic subtypes in Ethiopian breast cancer patient
por: Desalegn, Zelalem, et al.
Publicado: (2022)

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
por: Qin, Miao, et al.
Publicado: (2023)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer
por: Hu, Jiayue, et al.
Publicado: (2023)

Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
por: Håkansson, A, et al.
Publicado: (2001)

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
por: Lee, H E, et al.
Publicado: (2008)

Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.
por: Tsunoda, T., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_m186cgi63a40n081diqapev2iv